When was Frontier Bio founded?

Frontier Bio was founded in 2018 and raised its 1st funding round 1 year after it was founded.

Where is Frontier Bio located?

Frontier Bio is headquartered in Hayward, United States.

How many employees does Frontier Bio have?

As of Sep 30, 2026, the latest employee count at Frontier Bio is 7.

Is Frontier Bio a funded company?

Frontier Bio is a funded company, having raised a total of $380K across 5 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on May 02, 2019.

When was the latest funding round of Frontier Bio?

Frontier Bio's latest funding was a $***** Series A round on Oct 27, 2026, with participation from 0 investor.

Where does Frontier Bio rank among its competitors?

Frontier Bio ranks 1st amongst 13 active competitors, of which 3 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Frontier Bio, which secured an undisclosed amount in Aug, 2025.

Who are the top competitors of Frontier Bio?

Frontier Bio's top competitors include Cellivate Technologies, Vitti Labs and 3D Bio-Tissues. Among them, Frontier Bio secured the most recent funding round in October, 2026.

Frontier Bio - 2026 Company Profile, Funding & Competitors

Frontier Bio is a series A company based in Hayward (United States), founded in 2018. It operates as a Developer of engineered tissues to replace animal studies. Frontier Bio has raised $380K in funding from Alchemist Accelerator and Brinc. The company has 13 active competitors, including 3 funded and 1 that has exited. Its top competitors include companies like Cellivate Technologies, Vitti Labs and 3D Bio-Tissues.

Company Details

Developer of engineered tissues to replace animal studies. The company is creating lab-grown human tissues in the areas of lung, brain, and blood vessels can be used for more accurate medical device testing, drug development, surgical training, and disease modeling.

Website: www.frontierbio.com/
Email ID: *****@frontierbio.com

Key Metrics

Founded Year

2018

Location

Hayward, United States

Stage

Series A

Total Funding

$380K in 5 rounds

Latest Funding Round

Series A, Oct 27, 2026, $*****

Investors

Alchemist Accelerator & 9 more

Ranked

1^st among 13 active competitors

Employee Count

7 as on Sep 30, 2026

Similar Companies

Cellivate Technologies & 11 more

View Frontier Bio's full profile

Frontier Bio is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
FRONTIER BIO CORPORATION CIN: 6849124 , United States, Active	Apr 16, 2018	-	8 (As on Dec 31, 2024)	-

Frontier Bio has raised a total funding of $380K over 5 rounds. Its first funding round was on May 02, 2019. Frontier Bio has 10 institutional investors.

Here is the list of recent funding rounds of Frontier Bio:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 27, 2026	4099907	Series A	7951617	8534378	6047532	3346151
Aug 29, 2025	9530988	Seed	5455617	6597958	2902610	https://www.id.life/
Aug 10, 2021	3517340	Grant (prize money)	5311695	9511531	5388115	America’s Seed Fund & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Frontier Bio's funding rounds and investors

Frontier Bio's employee count trend

Frontier Bio has 7 employees as of Sep 26. Here is Frontier Bio's employee count trend over the years:

Uncover Frontier Bio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Frontier Bio include Cellivate Technologies, Vitti Labs and 3D Bio-Tissues. Here is the list of Top 10 competitors of Frontier Bio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Frontier Bio 2018, Hayward (United States), Series A	Developer of engineered tissues to replace animal studies	$380K	Alchemist Accelerator, KKR & 8 others	46/100
2nd	Cellivate Technologies 2019, Singapore (Singapore), Seed	Developer of nanotechnology to study issues related to growing cells	$2.03M	Antler, Venture Catalysts & 4 others	42/100
3rd	Vitti Labs 2019, Liberty (United States), Unfunded	Provider of human tissue products for life science research and development	-	-	38/100
4th	3D Bio-Tissues 2018, Newcastle Upon Tyne (United Kingdom), Acquired	Developer of a technology platform for tissue engineering	-	CULT Food Science, EIT Food	33/100
5th	OrganoLinX Therapeutics 2018, Toronto (Canada), Unfunded	Developer of 3D brain tissue biotechnology for applications in drug discovery, disease modeling, and cell therapy	-	-	24/100
6th	Advanced Tissue Services 2012, Tucson (United States), Unfunded	Provider of human biospecimens for clinical and translational research	-	-	24/100
7th	Polyphron New York City (United States), Unfunded	Developer of immune compatible human tissue grafts using biological automation	-	-	22/100
8th	QuantaCell 2014, Pessac (France), Unfunded	Provider of AI-powered software and data analysis for biomedical imaging	-	-	18/100
9th	Histidea 2015, Belgium, Unfunded	Provider of histopathology and cytology services for medical research applications	-	-	18/100
10th	Kamuanaku Tissue 2025, Portugal, Unfunded	Developer of medical devices and provider of tissue engineering services	-	-	16/100